SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

IRLAB Therapeutics Receives US Patent Allowance for Parkinson’s Candidate IRL1117

IRLAB Therapeutics says it has received a US patent allowance for its Parkinson’s drug candidate IRL1117.

Related stories